• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chem Phys Lett. Identification of Potential Binders of the Main Protease 3CLpro of the COVID-19 via Structure-Based Ligand Design and Molecular Model

tetano

Editor, Senior Moderator
Chem Phys Lett. 2020 Apr 18:137489. doi: 10.1016/j.cplett.2020.137489. [Epub ahead of print]
Identification of Potential Binders of the Main Protease 3CL[SUP]pro[/SUP] of the COVID-19 via Structure-Based Ligand Design and Molecular Modeling.


Macchiagodena M[SUP]1[/SUP], Pagliai M[SUP]1[/SUP], Procacci P[SUP]1[/SUP].

Author information




Abstract

We have applied a computational strategy, using a combination of virtual screening, docking and molecular dynamics techniques, aimed at identifying possible lead compounds for the non-covalent inhibition of the main protease 3CL[SUP]pro[/SUP] of the SARS-CoV2 Coronavirus. Based on the X-ray structure (PDB code: 6LU7), ligands were generated using a multimodal structure-based design and then docked to the monomer in the active state. Docking calculations show that ligand-binding is strikingly similar in SARS-CoV and SARS-CoV2 main proteases. The most potent docked ligands are found to share a common binding pattern with aromatic moieties connected by rotatable bonds in a pseudo-linear arrangement.
? 2020 Elsevier B.V. All rights reserved.



KEYWORDS:

3CL-PRO; 3CL-PRO inhibitor; Binding affinity; COVID-19; Coronavirus; Coronavirus main protease; Molecular Docking; Molecular dynamics; SARS-CoV2


PMID:32313296PMCID:PMC7165110DOI:10.1016/j.cplett.2020.137489
 
Back
Top